Fetoplacental transmission and placental response to SARS-CoV-2: Evidence from the literature

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a dreadful novel coronavirus with global health concerns among pregnant women. To date, the vertical transmission of SARS-CoV-2 during pregnancy remains controversial. We briefly report recent findings of placental response to SARS-CoV-2 infection and updates on vertical transmission. We systematically searched PubMed and Google Scholar databases according to PRISMA guidelines for studies reporting the effects of SARS-CoV-2 infection on the placenta and possibility of vertical transmission. We identified 45 studies reporting 1,280 human placentas that were analyzed by molecular pathology methods and 11,112 placenta-derived cells from a publicly available database that was analyzed using bioinformatics tools. The main finding of this study is that the SARS-CoV-2 canonical entry receptors (ACE2 and TMPRSS2) are abundantly expressed on the placenta during the first trimester, and this expression diminishes across gestational age. Out of 45 eligible studies identified, 24 (53.34%) showed no evidence of vertical transmission, 15 (33.33%) supported the hypothesis of very rare, low possibility of vertical transmission and 6 (13.33%) were indecisive and had no comment on vertical transmission. Furthermore, 433 placentas from 12 studies were also identified for placental pathology investigation. There was evidence of at least one form of maternal vascular malperfusion (MVM), 57/433 (13.1%), fetal vascular malperfusion (FVM), 81/433 (18.7%) and placental inflammation with excessive infiltration of CD3+ CD8+ lymphocytes, CD68+ macrophages and CD20+ lymphocytes in most of the eligible studies. Decidual vasculopathy (3.2%), infarction (3.2%), chronic histiocytic intervillositis (6.0%), thrombi vasculopathy (5.1%) were also observed in most of the MVM and FVM reported cases. The results indicated that SARS-CoV-2 induces placenta inflammation, and placenta susceptibility to SARS-CoV-2 decreases across the pregnancy window. Thus, SARS-CoV-2 infection in early pregnancy may adversely affect the developing fetus.

Integration of Omics Data and Network Models to Unveil Negative Aspects of SARS-CoV-2, from Pathogenic Mechanisms to Drug Repurposing

“…Due to the spread of SARS-CoV-2 infection, many efforts have also been dedicated to the investigation of maternal, fetal/placental and neonatal immunity, even following vaccination [ 33 , 34 , 35 ]. Comparative studies have highlighted alterations in the activation of systemic cytokines and peripheral leukocytes between pregnant and non-pregnant COVID-19 patients [ 36 , 37 ].…”

Angiotensin Converting Enzyme 2 (ACE2) - A macromolecule and its impact on human reproduction during COVID-19 pandemic

“…Many authors are investigating ACE2 and its impact on COVID 19 transmission, particularly on SARS-CoV-2 process-related genes. This will provide enormous ideas about virus transmission and reproduction Ezechukwu et al 2022). The singlecell RNA sequencing method helps the researchers to tabulate all the data required.…”

Pregnancy Outcomes, Immunophenotyping and Immunohistochemical Findings in a Cohort of Pregnant Patients with COVID-19—A Prospective Study

“…On the other hand, the receptor angiotensin-converting enzyme 2 (ACE2), used by SARS-CoV-2 for infecting pulmonary cells, was also found in placental tissue [ 22 , 23 , 24 ], supporting the idea of vertical transmission for this type of infection [ 25 , 26 ]. Recent investigations of placental pathologies indicated the presence of feto-maternal vascular malperfusion and placental inflammation with excessive infiltration of CD3+ CD8+ lymphocytes, CD68+ macrophages, and CD20+ lymphocytes [ 27 , 28 , 29 ].…”